Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease

Tomomi Kogiso,Yuri Ogasawara,Makiko Taniai,Eriko Shimada,Kei Inai,Katsutoshi Tokushige,Yousuke Nakai
DOI: https://doi.org/10.1007/s00535-024-02168-x
2024-11-28
Journal of Gastroenterology
Abstract:Fontan-associated liver disease (FALD) is a type of progressive liver fibrosis that occurs following Fontan surgery and can be complicated by hepatocellular carcinoma (HCC). Established treatments for FALD are lacking. Therefore, we investigated the efficacy of ursodeoxycholic acid (UDCA) in patients with FALD.
gastroenterology & hepatology
What problem does this paper attempt to address?